Singapore markets closed

Telix Pharmaceuticals Limited (TLX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
18.65+0.25 (+1.36%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 6.23B
Enterprise value 6.13B
Trailing P/E 1.16k
Forward P/E 60.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.99
Price/book (mrq)41.86
Enterprise value/revenue 12.34
Enterprise value/EBITDA 266.81

Trading information

Stock price history

Beta (5Y monthly) 2.43
52-week change 366.22%
S&P500 52-week change 323.20%
52-week high 319.06
52-week low 38.20
50-day moving average 316.27
200-day moving average 312.17

Share statistics

Avg vol (3-month) 31.21M
Avg vol (10-day) 31.38M
Shares outstanding 5334.23M
Implied shares outstanding 6334.23M
Float 8257.99M
% held by insiders 141.49%
% held by institutions 112.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.50%
Operating margin (ttm)16.29%

Management effectiveness

Return on assets (ttm)14.52%
Return on equity (ttm)24.26%

Income statement

Revenue (ttm)576.27M
Revenue per share (ttm)1.80
Quarterly revenue growth (yoy)72.80%
Gross profit (ttm)N/A
EBITDA 91.39M
Net income avi to common (ttm)31.68M
Diluted EPS (ttm)0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)122.71M
Total cash per share (mrq)0.38
Total debt (mrq)19.08M
Total debt/equity (mrq)10.53%
Current ratio (mrq)1.63
Book value per share (mrq)0.56

Cash flow statement

Operating cash flow (ttm)26.91M
Levered free cash flow (ttm)23.28M